Naperville, IL -- (SBWIRE) -- 12/26/2014 -- Reportstack, provider of premium market research reports announces the addition of HbA1c Testing Market in India 2014 market report to its offering
Netscribes latest market research report titled HbA1c Testing Market in India 2014 states that with the increasing incidence of diabetes in the country, the demand for HbA1c testing is rising. India is characterized by the presence of a large diabetic population. The countrys status as the diabetes capital of the world has made the need for diabetes prevention and screening very important. Hence, tests for measuring the blood glucose levels are facing high demand within the country. Naturally, HbA1c testing in the country is also benefiting from this trend. The ability to measure ones blood glucose levels over a period of 3 months has made it a test favored by many diabetics as well as people who believe they are at high risk of developing diabetes. The market for HbA1c testing has been growing steadily and with the awareness level regarding it increasing rapidly, the market is set to boom in the next few years.
Although the test is considered to be very useful for diabetes screening as well as for monitoring the diabetes status of a patient, its much higher cost compared to a simple blood sugar level test can act as a hindrance to its greater acceptance. However, the need to go for HbA1c tests only 3-4 times a year unlike the blood sugar level test which may have to be done on a monthly basis may work in favor of the former. Moreover, HbA1c tests give a clearer picture of the diabetes status of a patient as it a measurement of the glucose levels over a longer period. Several physicians also prescribe this test to their patients which in turn will increase its demand and thereby drive growth in the market.
Several large diagnostic chains offer these tests in India. Majority of the patients going for these tests are confirmed diabetics with very few non-diabetics undergoing this test. Most of the patients visiting laboratories for HbA1c tests have been prescribed to go for this test by a physician and very few people opt for the test on their own. However, with increasing awareness among people, this ratio is likely to change and many more people are expected to go for this test independently.
1. Abbott India Ltd.
2. Siemens Ltd.
3. Tosoh Corporation
1. Apollo Health and Life Styles Ltd.
2. Axis-Shield plc
3. Bayer Pharmaceuticals Pvt. Ltd.
4. Beckman Coulter India Pvt. Ltd.
5. Bio-Rad Laboratories (India) Pvt. Ltd.
6. Dr. Lal Pathlabs Pvt. Ltd.
7. Metropolis Healthcare Ltd.
8. Quest Diagnostics India Pvt. Ltd.
9. S Serum Analysis Centre Pvt. Ltd.
10. SRL Diagnostics Pvt. Ltd.
11. Thyrocare Diagnostics Pvt. Ltd.
12. Transasia Bio-medicals Ltd.
13. Trivitron Healthcare Pvt. Ltd.
Complete report is available @